Stanford University
Showing 1,251-1,300 of 2,069 Results
-
Suleiman Hodali
Postdoctoral Scholar, Comparative Literature
BioSuleiman Hodali received a PhD in comparative literature from UCLA. He is a 2025-27 Postdoctoral Scholar in Comparative Literature at Stanford University, and was previously a 2025-26 UC President's Postdoctoral Fellow at UC Riverside.
His research and teaching are situated at the intersections of several different fields, including eighteenth and nineteenth century studies, British Romanticism, translation theory, modern Arabic literature and culture, literary and critical theory, the history of ideas, colonial and postcolonial theory and criticism.
Recent and forthcoming writings appear in such publications as Studies in Romanticism, South Atlantic Quarterly, Political Concepts: A Critical Lexicon, and Ebb Magazine.
He is presently completing his first book project, titled, New Jerusalems, Modern Crusades: Holy Lands in the Imaginative Geography of Empire. -
Ian Hodder
Dunlevie Family Professor, Emeritus
BioIan Hodder joined the Department of Cultural and Social Anthropology in September of 1999. Among his publications are: Symbols in Action (Cambridge 1982), Reading the Past (Cambridge 1986), The Domestication of Europe (Oxford 1990), The Archaeological Process (Oxford 1999). Catalhoyuk: The Leopard's Tale (Thames and Hudson 2006), and Entangled. An archaeology of the relationships between humans and things (Wiley and Blackwell, 2012). Professor Hodder has been conducting the excavation of the 9,000 year-old Neolithic site of Catalhoyuk in central Turkey since 1993. The 25-year project has three aims - to place the art from the site in its full environmental, economic and social context, to conserve the paintings, plasters and mud walls, and to present the site to the public. The project is also associated with attempts to develop reflexive methods in archaeology. Dr. Hodder is currently the Dunlevie Family Professor Emeritus.
-
Amy E. Hodge
Science Data Librarian, Research Data Services Admin
Current Role at StanfordAmy assists members of the Stanford community with the sharing and preservation of research data and other research products in the Stanford Digital Repository (SDR). She serves as the Product Owner for the Libraries' self-deposit application for the SDR and as the Product Owner for the upcoming Data Catalog project. Amy assists researchers with large data deposits for the SDR and serves on several groups that work to better enable access to research data at Stanford. Amy also co-manages Stanford Libraries' campus DOI service.
-
Keith Hodgson
David Mulvane Ehrsam and Edward Curtis Franklin Professor of Chemistry and Professor of Photon Science
BioCombining inorganic, biophysical and structural chemistry, Professor Keith Hodgson investigates how structure at molecular and macromolecular levels relates to function. Studies in the Hodgson lab have pioneered the use of synchrotron x-radiation to probe the electronic and structural environment of biomolecules. Recent efforts focus on the applications of x-ray diffraction, scattering and absorption spectroscopy to examine metalloproteins that are important in Earth’s biosphere, such as those that convert nitrogen to ammonia or methane to methanol.
Keith O. Hodgson was born in Virginia in 1947. He studied chemistry at the University of Virginia (B.S. 1969) and University of California, Berkeley (Ph.D. 1972), with a postdoctoral year at the ETH in Zurich. He joined the Stanford Chemistry Department faculty in 1973, starting up a program of fundamental research into the use of x-rays to study chemical and biological structure that made use of the unique capabilities of the Stanford Synchrotron Radiation Lightsource (SSRL). His lab carried out pioneering x-ray absorption and x-ray crystallographic studies of proteins, laying the foundation for a new field now in broad use worldwide. In the early eighties, he began development of one of the world's first synchrotron-based structural molecular biology research and user programs, centered at SSRL. He served as SSRL Director from 1998 to 2005, and SLAC National Accelerator Laboratory (SLAC) Deputy Director (2005-2007) and Associate Laboratory Director for Photon Science (2007-2011).
Today the Hodgson research group investigates how molecular structure at different organizational levels relates to biological and chemical function, using a variety of x-ray absorption, diffraction and scattering techniques. Typical of these molecular structural studies are investigations of metal ions as active sites of biomolecules. His research group develops and utilizes techniques such as x-ray absorption and emission spectroscopy (XAS and XES) to study the electronic and metrical details of a given metal ion in the biomolecule under a variety of natural conditions.
A major area of focus over many years, the active site of the enzyme nitrogenase is responsible for conversion of atmospheric di-nitrogen to ammonia. Using XAS studies at the S, Fe and Mo edge, the Hodgson group has worked to understand the electronic structure as a function of redox in this cluster. They have developed new methods to study long distances in the cluster within and outside the protein. Studies are ongoing to learn how this cluster functions during catalysis and interacts with substrates and inhibitors. Other components of the protein are also under active study.
Additional projects include the study of iron in dioxygen activation and oxidation within the binuclear iron-containing enzyme methane monooxygenase and in cytochrome oxidase. Lab members are also investigating the role of copper in electron transport and in dioxygen activation. Other studies include the electronic structure of iron-sulfur clusters in models and enzymes.
The research group is also focusing on using the next generation of x-ray light sources, the free electron laser. Such a light source, called the LCLS, is also located at SLAC. They are also developing new approaches using x-ray free electron laser radiation to image noncrystalline biomolecules and study chemical reactivity on ultrafast time scales. -
Christian Hoerner
Sr Research Scientist-Basic Life, Medicine - Med/Oncology
Current Role at StanfordSenior Scientist and Lab Manager, Alice Fan Lab
-
Andrew R. Hoffman
Professor of Medicine (Endocrinology), Emeritus
Current Research and Scholarly InterestsMechanism of genomic imprinting of insulin like growth factor-2 and other genes.Long range chromatin interactions Role of histone modifications and DNA methylation in gene expression.
-
Seth Ari Sim-Son Hoffman
Instructor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsClinical research to benefit underserved populations.
-
Florian Hoffmann, Ph.D.
Postdoctoral Scholar, Hematology
BioFlorian is a postdoctoral researcher in Dr. Ami Bhatt's laboratory at Stanford University. He earned his Ph.D. in Biochemistry working in Dr. Sam Sternberg's group at Columbia University where he studied atypical CRISPR systems in prokaryotes, in search of molecular tools for programmable gene editing and gene regulation. His studies elucidate the mechanisms of a novel RNA-guided transposition system, the evolutionary ancestors of the gene editing enzymes Cas9 and Cas12, and an unprecedented Cas12f enzyme that creates custom de novo transcription start sites without requiring promoter elements. Florian is fascinated by the vast untapped resources of novel gene functions encoded in bacteria and their viruses (bacteriophages). He is an inventor on multiple patents related to his doctoral work. During his postdoctoral work at Stanford, he aims to discover novel paradigms of bacteria-virus interactions and how these shape the human gut microbiome, and human health. To investigate these systems, he harnesses interdisciplinary approaches, combining computational gene discovery with experimental techniques in Molecular Biology, Genetics and Biochemistry.
-
Manuel Hoffmann
Affiliate, Center for Population Health Sciences
Biowww.manuelhoffmann.org
-
Matthias C. Hoffmann
Lead Scientist, SLAC National Accelerator Laboratory
Current Role at StanfordLead scientist in the LCLS Laser Science Department.
Group lead for Mid-infrared and THz sources.
Develops and supports THz pump-X-ray probe experiments at LCLS and in-house research on ultrafast spectroscopy with intense THz pulses. -
Bernd Hofmann
Postdoctoral Scholar, Electrical Engineering
BioBernd Hofmann received the B.Eng. degree in electrical engineering from the Augsburg University of Applied Sciences, Augsburg, Germany, in 2015, and the M.Sc. and Dr.-Ing. degrees in electrical engineering from the Technical University of Munich (TUM), Munich, Germany, in 2017 and 2024, respectively.
From Jan. 2025 to Feb. 2026, he was a postdoctoral scholar at the University of Southern California, CA. Since Mar. 2026 he is a postdoctoral scholar with the Stanford University. His current research interests include computational electromagnetics, in particular, high-order accurate integral equation methods, and antenna near-field measurement techniques. -
Lawrence "Rusty" Hofmann, MD
Professor of Radiology (Interventional Radiology)
BioDr. Lawrence “Rusty” Hofmann is an actively practicing physician and Professor of Interventional Radiology at Stanford School of Medicine, as well as the Chief of Industry Partnerships for Stanford Healthcare, Medical Director of Cardiac and Interventional Services, and the Medical Director of Digital Health at Stanford Medicine. He served as Chief of Interventional Radiology at Stanford for nearly two decades. He is the Co-Founder of Grand Rounds, Inc, rebranded as Included Health. He has devoted his career to providing state-of-the-art care to patients at either Johns Hopkins, where he practiced for 10 years, or Stanford, where he practiced for 15 years. He has published over 100 scientific articles on minimally invasive treatment of blood clots (DVT) and cancer. He has always had in interest in innovation. He holds 2 patents, has worked as a consultant for numerous medical device companies, both start-ups and large companies and is currently the Global-Principal Investigator for the first clinical trial testing a venous stent. He has invented and brought a number of devices from napkin stage to world-wide use. He has active digital health research projects at the intersection of artificial intelligence and clinical care, including telemedicine and deep venous thrombosis.
